Mark Steven Pasternack, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meningococcal Infections | 1 | 2007 | 78 | 0.280 |
Why?
|
| Neisseria meningitidis | 1 | 2007 | 111 | 0.280 |
Why?
|
| Infectious Mononucleosis | 1 | 2007 | 133 | 0.270 |
Why?
|
| Severe Combined Immunodeficiency | 2 | 2021 | 235 | 0.220 |
Why?
|
| T-Lymphocytes, Cytotoxic | 6 | 2000 | 1803 | 0.220 |
Why?
|
| Arthritis, Infectious | 1 | 2007 | 348 | 0.220 |
Why?
|
| Campylobacter Infections | 1 | 2002 | 32 | 0.210 |
Why?
|
| Blood Bactericidal Activity | 1 | 1999 | 124 | 0.170 |
Why?
|
| Dysgammaglobulinemia | 1 | 2019 | 19 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2000 | 370 | 0.160 |
Why?
|
| Haptoglobins | 1 | 1999 | 165 | 0.150 |
Why?
|
| Granulocytes | 1 | 1999 | 551 | 0.140 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1999 | 660 | 0.140 |
Why?
|
| Whooping Cough | 1 | 1997 | 87 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 1 | 2000 | 1083 | 0.130 |
Why?
|
| Immunoglobulin A | 1 | 2019 | 992 | 0.120 |
Why?
|
| Mandibular Diseases | 1 | 2016 | 117 | 0.120 |
Why?
|
| Burns | 6 | 2012 | 1901 | 0.120 |
Why?
|
| Neonatal Screening | 3 | 2021 | 619 | 0.110 |
Why?
|
| Islets of Langerhans | 1 | 2000 | 1351 | 0.110 |
Why?
|
| Phagocytosis | 1 | 1999 | 1530 | 0.110 |
Why?
|
| Pancreas | 1 | 2000 | 1700 | 0.110 |
Why?
|
| Debridement | 1 | 2016 | 494 | 0.110 |
Why?
|
| Serine Endopeptidases | 3 | 2000 | 1027 | 0.100 |
Why?
|
| Immunization | 1 | 1997 | 1220 | 0.100 |
Why?
|
| Adenosine Triphosphate | 2 | 2003 | 2003 | 0.100 |
Why?
|
| Lyme Neuroborreliosis | 1 | 2012 | 50 | 0.100 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 1998 | 1356 | 0.100 |
Why?
|
| Osteomyelitis | 1 | 2016 | 408 | 0.100 |
Why?
|
| Minocycline | 1 | 2012 | 170 | 0.090 |
Why?
|
| Parainfluenza Virus 1, Human | 1 | 1990 | 25 | 0.090 |
Why?
|
| Paramyxoviridae Infections | 1 | 1990 | 57 | 0.090 |
Why?
|
| Rifampin | 1 | 2012 | 351 | 0.090 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2019 | 1508 | 0.080 |
Why?
|
| Immunity, Cellular | 2 | 1992 | 1560 | 0.080 |
Why?
|
| Catheter-Related Infections | 1 | 2012 | 275 | 0.080 |
Why?
|
| Laryngeal Diseases | 1 | 2012 | 248 | 0.080 |
Why?
|
| Streptococcal Infections | 2 | 2003 | 619 | 0.070 |
Why?
|
| Neutrophils | 1 | 2020 | 3785 | 0.070 |
Why?
|
| Catheterization, Central Venous | 1 | 2012 | 536 | 0.070 |
Why?
|
| Cell Death | 1 | 1992 | 1682 | 0.070 |
Why?
|
| Cytomegalovirus Infections | 2 | 1990 | 839 | 0.070 |
Why?
|
| Meningococcal Vaccines | 1 | 2007 | 96 | 0.070 |
Why?
|
| Serotyping | 1 | 2007 | 331 | 0.070 |
Why?
|
| Sarcoidosis | 1 | 2012 | 535 | 0.070 |
Why?
|
| Bacterial Capsules | 1 | 2007 | 247 | 0.070 |
Why?
|
| Cytokines | 2 | 2020 | 7453 | 0.060 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2007 | 582 | 0.060 |
Why?
|
| Streptococcus milleri Group | 1 | 2003 | 6 | 0.050 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2003 | 14 | 0.050 |
Why?
|
| Arthralgia | 1 | 2007 | 459 | 0.050 |
Why?
|
| Burn Units | 2 | 2012 | 143 | 0.050 |
Why?
|
| Gonorrhea | 1 | 2007 | 355 | 0.050 |
Why?
|
| Foodborne Diseases | 1 | 2002 | 41 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5716 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 1991 | 1891 | 0.050 |
Why?
|
| HL-60 Cells | 2 | 2000 | 364 | 0.050 |
Why?
|
| Pediatrics | 1 | 2017 | 3628 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 1991 | 2452 | 0.050 |
Why?
|
| Proteome | 1 | 2012 | 1891 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 4 | 2016 | 7478 | 0.050 |
Why?
|
| Wound Infection | 2 | 1994 | 243 | 0.050 |
Why?
|
| Enteritis | 1 | 2002 | 164 | 0.050 |
Why?
|
| Hypotension | 1 | 2007 | 888 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 6131 | 0.050 |
Why?
|
| Orbital Diseases | 1 | 2003 | 178 | 0.050 |
Why?
|
| Eye Infections, Bacterial | 1 | 2003 | 239 | 0.040 |
Why?
|
| Tubulin | 1 | 2003 | 695 | 0.040 |
Why?
|
| Insulinoma | 1 | 2000 | 122 | 0.040 |
Why?
|
| Acyclovir | 1 | 2000 | 267 | 0.040 |
Why?
|
| Fever | 1 | 2007 | 1619 | 0.040 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1999 | 221 | 0.040 |
Why?
|
| Abscess | 1 | 2003 | 606 | 0.040 |
Why?
|
| Streptococcus pyogenes | 1 | 2001 | 293 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2000 | 739 | 0.040 |
Why?
|
| Granzymes | 3 | 2000 | 278 | 0.040 |
Why?
|
| Complement System Proteins | 1 | 2002 | 738 | 0.040 |
Why?
|
| Proteoglycans | 2 | 2000 | 809 | 0.040 |
Why?
|
| Mitosis | 1 | 2003 | 1181 | 0.040 |
Why?
|
| Caspases | 2 | 2000 | 881 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2003 | 854 | 0.040 |
Why?
|
| Penicillins | 1 | 2001 | 406 | 0.040 |
Why?
|
| Viruses | 1 | 2002 | 373 | 0.040 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 1998 | 122 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 7957 | 0.040 |
Why?
|
| Gene Library | 1 | 2000 | 1062 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 13427 | 0.040 |
Why?
|
| Chemokine CCL5 | 1 | 1998 | 214 | 0.040 |
Why?
|
| Herpes Simplex | 1 | 2000 | 470 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2000 | 818 | 0.030 |
Why?
|
| Cross Infection | 2 | 1997 | 1425 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 1991 | 5804 | 0.030 |
Why?
|
| Infant | 7 | 2021 | 36556 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2003 | 17629 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 1999 | 705 | 0.030 |
Why?
|
| Trypsin | 2 | 2000 | 491 | 0.030 |
Why?
|
| Substrate Specificity | 3 | 2000 | 1751 | 0.030 |
Why?
|
| Vaccines, Inactivated | 1 | 1997 | 186 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 13021 | 0.030 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2001 | 641 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 2749 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2000 | 2179 | 0.030 |
Why?
|
| Humans | 29 | 2021 | 768970 | 0.030 |
Why?
|
| Dogs | 1 | 2000 | 3845 | 0.030 |
Why?
|
| Cytoplasmic Granules | 1 | 1998 | 574 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 4168 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1999 | 1418 | 0.030 |
Why?
|
| Toxoplasmosis, Congenital | 1 | 1994 | 8 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1997 | 542 | 0.030 |
Why?
|
| Research Report | 1 | 2017 | 369 | 0.030 |
Why?
|
| T-Lymphocytes | 2 | 1997 | 10276 | 0.030 |
Why?
|
| Vaccines, Synthetic | 1 | 1997 | 622 | 0.030 |
Why?
|
| Infant, Newborn | 5 | 2021 | 26428 | 0.030 |
Why?
|
| Methicillin Resistance | 1 | 1994 | 198 | 0.030 |
Why?
|
| Flavobacterium | 1 | 1993 | 20 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2000 | 1171 | 0.030 |
Why?
|
| Antiviral Agents | 2 | 2000 | 3070 | 0.030 |
Why?
|
| Massachusetts | 2 | 2021 | 8894 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2002 | 1761 | 0.030 |
Why?
|
| Lipid A | 1 | 1993 | 70 | 0.030 |
Why?
|
| Blood-Borne Pathogens | 1 | 2012 | 52 | 0.030 |
Why?
|
| Transfection | 1 | 2000 | 5763 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2002 | 3412 | 0.020 |
Why?
|
| Biopsy | 2 | 2016 | 6805 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2000 | 4625 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2001 | 1547 | 0.020 |
Why?
|
| Adolescent | 8 | 2019 | 89244 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2021 | 2574 | 0.020 |
Why?
|
| Limit of Detection | 1 | 2012 | 277 | 0.020 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 1993 | 238 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2021 | 2123 | 0.020 |
Why?
|
| Celiac Disease | 1 | 2019 | 820 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 6512 | 0.020 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2010 | 29 | 0.020 |
Why?
|
| Child, Preschool | 6 | 2016 | 42683 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2003 | 4939 | 0.020 |
Why?
|
| Hydrolysis | 1 | 1991 | 646 | 0.020 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2012 | 311 | 0.020 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1991 | 174 | 0.020 |
Why?
|
| Histones | 1 | 2000 | 2603 | 0.020 |
Why?
|
| Child | 7 | 2019 | 80960 | 0.020 |
Why?
|
| Retrospective Studies | 6 | 2019 | 81903 | 0.020 |
Why?
|
| Ascitic Fluid | 1 | 1989 | 189 | 0.020 |
Why?
|
| Base Sequence | 1 | 2000 | 12430 | 0.020 |
Why?
|
| Medicine | 1 | 2017 | 947 | 0.020 |
Why?
|
| Female | 11 | 2020 | 397515 | 0.020 |
Why?
|
| Ganciclovir | 1 | 1989 | 256 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 1731 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 2010 | 238 | 0.020 |
Why?
|
| Age of Onset | 1 | 2016 | 3346 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 1645 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 800 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2010 | 963 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1999 | 10765 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1999 | 4213 | 0.020 |
Why?
|
| Calcium | 1 | 2000 | 5792 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 2280 | 0.020 |
Why?
|
| Population Surveillance | 1 | 1997 | 2597 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 1994 | 1430 | 0.020 |
Why?
|
| Age Distribution | 1 | 2012 | 2875 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 1994 | 1398 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1988 | 896 | 0.020 |
Why?
|
| Animals | 8 | 2002 | 169335 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2016 | 3586 | 0.020 |
Why?
|
| Bacteremia | 1 | 2012 | 985 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 1993 | 2222 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10633 | 0.020 |
Why?
|
| Reference Values | 1 | 2012 | 4940 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 984 | 0.010 |
Why?
|
| Lymphokines | 1 | 1988 | 927 | 0.010 |
Why?
|
| Young Adult | 3 | 2020 | 60131 | 0.010 |
Why?
|
| ROC Curve | 1 | 2012 | 3629 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2012 | 22296 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2012 | 1965 | 0.010 |
Why?
|
| Demecolcine | 1 | 2003 | 18 | 0.010 |
Why?
|
| Program Development | 1 | 2010 | 1300 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6236 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1991 | 5033 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2003 | 2474 | 0.010 |
Why?
|
| Sphenoid Sinusitis | 1 | 2003 | 10 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1988 | 1616 | 0.010 |
Why?
|
| Ethmoid Sinusitis | 1 | 2003 | 25 | 0.010 |
Why?
|
| U937 Cells | 1 | 2003 | 260 | 0.010 |
Why?
|
| Recurrence | 1 | 2016 | 8513 | 0.010 |
Why?
|
| Adult | 5 | 2012 | 223851 | 0.010 |
Why?
|
| Tubulin Modulators | 1 | 2003 | 106 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1988 | 1231 | 0.010 |
Why?
|
| Proteins | 1 | 1997 | 6011 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2000 | 5443 | 0.010 |
Why?
|
| DNA Damage | 1 | 1992 | 2472 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2012 | 2167 | 0.010 |
Why?
|
| DNA | 2 | 2010 | 7214 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18435 | 0.010 |
Why?
|
| Exophthalmos | 1 | 2003 | 100 | 0.010 |
Why?
|
| Male | 8 | 2019 | 365203 | 0.010 |
Why?
|
| Acute Disease | 1 | 2012 | 7245 | 0.010 |
Why?
|
| Virus Diseases | 1 | 1988 | 724 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2010 | 2508 | 0.010 |
Why?
|
| Apoptosis | 1 | 1997 | 9527 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 2238 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2016 | 9384 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1997 | 8055 | 0.010 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2000 | 130 | 0.010 |
Why?
|
| Perforin | 1 | 2000 | 167 | 0.010 |
Why?
|
| HIV-1 | 1 | 1998 | 6962 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2003 | 1647 | 0.010 |
Why?
|
| Quality Indicators, Health Care | 1 | 2010 | 1812 | 0.010 |
Why?
|
| Complement Activation | 1 | 2002 | 447 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2019 | 41808 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 4413 | 0.010 |
Why?
|
| Deoxyribonucleases | 1 | 2000 | 209 | 0.010 |
Why?
|
| Mice | 5 | 2002 | 82072 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2019 | 6876 | 0.010 |
Why?
|
| K562 Cells | 1 | 2000 | 648 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2012 | 3800 | 0.010 |
Why?
|
| COS Cells | 1 | 2000 | 1135 | 0.010 |
Why?
|
| Chemokine CCL3 | 1 | 1998 | 85 | 0.010 |
Why?
|
| Chemokine CCL4 | 1 | 1998 | 127 | 0.010 |
Why?
|
| Caspase 2 | 1 | 1997 | 26 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 2417 | 0.010 |
Why?
|
| Enzyme Precursors | 1 | 1997 | 166 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 20776 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2016 | 65480 | 0.010 |
Why?
|
| Cell Line | 1 | 1991 | 15604 | 0.010 |
Why?
|
| Drainage | 1 | 2003 | 1184 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1997 | 185 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 240 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1997 | 340 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 2000 | 1049 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2010 | 8748 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1998 | 867 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 2231 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 4478 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2012 | 24333 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1993 | 9264 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1988 | 2258 | 0.010 |
Why?
|
| Caspase 3 | 1 | 1997 | 731 | 0.010 |
Why?
|
| Spiramycin | 1 | 1994 | 3 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 6023 | 0.010 |
Why?
|
| Sulfadiazine | 1 | 1994 | 18 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1988 | 4492 | 0.010 |
Why?
|
| United States | 1 | 2002 | 73186 | 0.010 |
Why?
|
| Clone Cells | 1 | 1998 | 1670 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2012 | 39394 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 1994 | 328 | 0.010 |
Why?
|
| Pyrimethamine | 1 | 1994 | 95 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 21547 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3775 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1989 | 4756 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 15471 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2001 | 4040 | 0.010 |
Why?
|
| Heparin | 1 | 2000 | 1636 | 0.010 |
Why?
|
| Antibodies, Protozoan | 1 | 1994 | 251 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 7460 | 0.010 |
Why?
|
| Leucovorin | 1 | 1994 | 643 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 1993 | 6232 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 20245 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 1998 | 1973 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1997 | 1194 | 0.010 |
Why?
|
| Catheterization | 1 | 1997 | 1431 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2000 | 2885 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1997 | 3588 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 8559 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1993 | 739 | 0.010 |
Why?
|
| Urinary Tract Infections | 1 | 1997 | 805 | 0.010 |
Why?
|
| Virus Replication | 1 | 1998 | 2458 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 1994 | 521 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2000 | 3713 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 14201 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1994 | 1528 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1989 | 412 | 0.010 |
Why?
|
| Chromatin | 1 | 2000 | 2981 | 0.000 |
Why?
|
| Retinal Diseases | 1 | 1994 | 710 | 0.000 |
Why?
|
| Immunocompromised Host | 1 | 1993 | 863 | 0.000 |
Why?
|
| Infection Control | 1 | 1994 | 985 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 3840 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 59739 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1998 | 5505 | 0.000 |
Why?
|
| Respiration, Artificial | 1 | 1997 | 2725 | 0.000 |
Why?
|
| Rats | 1 | 2002 | 23786 | 0.000 |
Why?
|
| Pneumonia | 1 | 1997 | 2164 | 0.000 |
Why?
|
| Aged | 2 | 2012 | 171786 | 0.000 |
Why?
|
| Mitochondria | 1 | 1997 | 3682 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 9618 | 0.000 |
Why?
|
| Monocytes | 1 | 1993 | 2603 | 0.000 |
Why?
|
| Middle Aged | 2 | 2012 | 223737 | 0.000 |
Why?
|
| Sepsis | 1 | 1997 | 2610 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1994 | 4568 | 0.000 |
Why?
|
| Boston | 1 | 1994 | 9377 | 0.000 |
Why?
|
| Prognosis | 1 | 2000 | 30046 | 0.000 |
Why?
|
| Time Factors | 1 | 1997 | 40261 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 36854 | 0.000 |
Why?
|
| HIV Infections | 1 | 1998 | 17591 | 0.000 |
Why?
|
| Risk Factors | 1 | 1997 | 74976 | 0.000 |
Why?
|